Post-Stroke Depression: A Review.

Area of Science:

• Neurology
• Psychiatry
• Clinical Medicine

Background:

• Poststroke depression (PSD) is a recognized psychiatric complication of stroke, with systematic studies beginning in the 1970s.
• Meta-analyses have been crucial due to small patient numbers in individual stroke studies, though some merged data may obscure findings like cognitive impairment.
• PSD significantly increases disability and mortality in stroke survivors.

Purpose of the Study:

• To review advances in the treatment and prevention of poststroke depression.
• To explore the evolving understanding of PSD pathophysiology.
• To highlight the clinical impact of PSD and its management.

Main Methods:

• Review of meta-analyses and randomized controlled trials (RCTs) on PSD treatment and prevention.
• Synthesis of current research on the etiological factors and mechanisms of PSD.
• Analysis of the impact of PSD on stroke recovery and long-term outcomes.

Main Results:

• Antidepressants are effective in both treating and preventing PSD, significantly reducing its incidence compared to placebo.
• Early antidepressant intervention for PSD shows promise in enhancing physical and cognitive recovery post-stroke.
• Potential survival benefits up to 10 years post-stroke are suggested with early PSD treatment.
• Emerging research points to inflammatory processes, genetic variations, white matter disease, and neurochemical changes as relevant etiological factors.

Conclusions:

• Antidepressant therapy represents a significant clinical advance for managing PSD, improving patient outcomes.
• Understanding the complex pathophysiology of PSD, including inflammatory and neurobiological factors, is crucial for developing targeted future treatments.
• Effective management of PSD is essential for optimizing stroke recovery, reducing long-term disability, and improving survival rates.